Paolo Parini was born in Rimini, Italy, in 1964. 
He gained his MD degree in 1990 at the Universita’ di Bologna, Italy. In 1994 he obtained his specialization in Gastroenterology and Hepatology (Universita’ di Bologna, Italy). The same year Parini was registered as PhD-student at the Karolinska Institutet, Sweden, under the supervision of Prof Mats Rudling and Prof Bo Angelin. In 1999, he obtained his PhD defending a thesis entitled “Hormonal regulation of hepatic cholesterol and lipoprotein metabolism: effects of estrogen and growth hormone” and since then his research activities are focused on the different aspect of lipoprotein metabolism in humans and in preclinical models.

Professor Parini’s postdoctoral activities have been performed at the Dept of Medicine, Karolinska Institutet, and in the lab of Prof Lawrence Rudel, Lipid Sciences, Wake Forest University School of Medicine Winston-Salem, NC, US. In 2006, he moved to the Dept of Laboratory Medicine, Karolinska Institutet, and created a research group together with Prof Mats Eriksson. From 2010 to 2016, Paolo Parini was the Director of the Division of Clinical Chemistry, Dept. of Laboratory Medicine, Karolinska Institutet. In 2011, he obtained the specialization in Clinical Chemistry (Swedish National Board of Health and Welfare) and in 2012 he become full professor in Clinical Chemistry at the Dept of Laboratory Medicine, Karolinska Institutet. Since 2015, his professorship became “translational” being located 50% at the Dept of Laboratory Medicine and 50% at the Dept of Medicine, Karolinska Institutet. Paolo Parini still see patients on regular basis at the Lipid Clinic of the Karolinska University Hospital.

Since January 2017, Professor Parini is also the Director of Research, Development, Education and Innovation at the Inflammation and Infection Theme, Karolinska University Hospital, Sweden. He is member of the Board of Internationalization of the Karolinska Institutet and member of the Scientific Committee of the Center E. Grossi Paoletti, Universita’ di Milano, Italy. Professor Parini also coordinate the European project HUMAN (EU FP7 no 602757).

Professor Parini serves on the Society’s Executive Committee as Treasurer since January 2018. He has represented Sweden in the Steering Committee of the European Lipoprotein Club (2005-2011) and is representing Sweden in the Steering Committee of the Scandinavian Society of Atherosclerosis Reseach since 2008. He has been the Chairman of the Scandinavian Society of Atherosclerosis Research between 2011 and 2015.

Contributions

EAS Advanced Course – Rare Lipid Disorders – Sweden & NorwayWebinars on-demandNetwork Medicine and Drug Repurposing in Cardiovascular DiseaseWebinars on-demand(ReviewTreatmentHypolipidemic drugs)New targets for controlling dyslipidaemias and atherosclerosis - chair86th EAS Congress 2018